Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_assertion type Assertion NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_head.
- NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_assertion wasGeneratedBy ECO_0000203 NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_provenance.
- NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_assertion wasDerivedFrom befree-20140225 NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_provenance.
- NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_assertion SIO_000772 11958417 NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_provenance.
- NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_assertion evidence source_evidence_literature NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_provenance.
- NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_assertion description "[The authors concluded that FGFR 4 must be an important factor which predicts short survival Grade III astrocytoma patients, who require strict adjuvant therapy in accordance with glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539057.RAEGDQ2mZeSCEXq3-HjEUYqRCp8zn_ebDxrfQKGJWhACM130_provenance.